Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001799191-24-000011

Chief Executive Officer returned 11,173 shares (to the company)

  • Chief Executive Officer acquired 198,517 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Virnich Daniel · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-21 Returned to the company : show line 1 in the form −11,173 $0.60 $6,673 718,430 D
2024-05-21 Grant or award : show line 2 in the form +198,517 916,947 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-21 Grant or award : show line 3 in the form Non-Qualified Stock Option (right to buy) +496,293 496,293 D
Loading xslF345X05/edgardoc.xml…